Institute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.
Leslie Dan Faculty of Pharmacy and Temerty Faculty of Medicine, University of Toronto, 100 Queensway West, Mississauga, Toronto, ON, L5B 1B8, Canada.
Drugs Aging. 2022 Oct;39(10):829-840. doi: 10.1007/s40266-022-00964-9. Epub 2022 Sep 15.
Prescribing cascades occur when a drug is prescribed to manage side effects of another drug, typically when a side effect is misinterpreted as a new condition. A consensus list of clinically important prescribing cascades that adversely affect older persons' health (i.e., where risks of the prescribing cascade usually exceed benefits) was developed to help identify, prevent, and manage prescribing cascades.
Three rounds of a modified Delphi process were conducted with a multidisciplinary panel of 38 clinicians from six countries with expertise in geriatric pharmacotherapy. The clinical importance of 139 prescribing cascades was assessed in Round 1. Cascades highly rated by ≥ 70% of panelists were included in subsequent rounds. Factors influencing ratings in Rounds 1 and 3 were categorized. After three Delphi rounds, highly rated prescribing cascades were reviewed by the study team to determine the final list of clinically important cascades consistent with potentially inappropriate prescribing.
After three rounds, 13 prescribing cascades were highly rated by panelists. Following a study team review, the final tool includes nine clinically important prescribing cascades consistent with potentially inappropriate prescribing. Panelists reported that their ratings were influenced by many factors (e.g., how commonly they encountered the medications involved and the cascade itself, the severity of side effects, availability of alternatives). The relative importance of these factors in determining clinical importance varied by panelist.
A nine-item consensus-based list of clinically important prescribing cascades, representing potentially inappropriate prescribing, was developed. Panelists' decisions about what constituted a clinically important prescribing cascade were multi-factorial. This tool not only raises awareness about these cascades but will also help clinicians recognize these and other important prescribing cascades. This list contributes to the prevention and management of polypharmacy and medication-related harm in older people.
当一种药物被开处方来治疗另一种药物的副作用时,就会发生处方级联,这种情况通常发生在副作用被误解为新病症时。为了帮助识别、预防和管理处方级联,制定了一份共识清单,列出了对老年人健康有不利影响的临床重要处方级联(即处方级联的风险通常超过益处)。
对来自六个国家的 38 名具有老年药物治疗专业知识的多学科临床医生进行了三轮改良 Delphi 流程。在第一轮中评估了 139 个处方级联的临床重要性。在后续轮次中,包含了被≥70%的小组成员高度评价的级联。对第 1 轮和第 3 轮的评分影响因素进行了分类。经过三轮 Delphi 流程,研究小组对被高度评价的处方级联进行了审查,以确定与潜在不适当处方一致的临床重要级联的最终列表。
经过三轮,13 个处方级联被小组成员高度评价。经过研究小组审查,最终工具包含 9 个与潜在不适当处方一致的临床重要处方级联。小组成员报告称,他们的评分受到许多因素的影响(例如,他们遇到涉及的药物和级联本身、副作用的严重程度、替代品的可用性等)。这些因素在确定临床重要性方面的相对重要性因小组成员而异。
制定了一份基于共识的 9 项临床重要处方级联清单,代表潜在不适当处方。小组成员对什么构成临床重要处方级联的决定是多因素的。该工具不仅提高了对这些级联的认识,还将帮助临床医生识别这些和其他重要的处方级联。该清单有助于预防和管理老年人的药物滥用和与药物相关的伤害。